Alps Advisors Inc. Has $436,000 Stake in Petmed Express Inc (PETS)

Alps Advisors Inc. grew its stake in Petmed Express Inc (NASDAQ:PETS) by 34.4% during the third quarter, HoldingsChannel.com reports. The firm owned 13,199 shares of the company’s stock after buying an additional 3,381 shares during the period. Alps Advisors Inc.’s holdings in Petmed Express were worth $436,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of PETS. Itau Unibanco Holding S.A. acquired a new stake in Petmed Express during the 2nd quarter worth $154,000. Weatherly Asset Management L. P. acquired a new stake in Petmed Express during the 2nd quarter worth $205,000. OppenheimerFunds Inc. acquired a new stake in Petmed Express during the 2nd quarter worth $205,000. Piedmont Investment Advisors LLC acquired a new stake in Petmed Express during the 2nd quarter worth $211,000. Finally, Schroder Investment Management Group acquired a new stake in Petmed Express during the 2nd quarter worth $214,000. 92.00% of the stock is currently owned by institutional investors.

Several analysts recently commented on the company. BidaskClub raised Petmed Express from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, July 18th. ValuEngine raised Petmed Express from a “strong sell” rating to a “sell” rating in a research note on Friday, October 26th. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $42.67.

Shares of Petmed Express stock opened at $28.09 on Friday. The firm has a market cap of $615.05 million, a P/E ratio of 15.43 and a beta of 0.84. Petmed Express Inc has a 12 month low of $27.20 and a 12 month high of $57.80.

Petmed Express (NASDAQ:PETS) last issued its quarterly earnings data on Monday, October 22nd. The company reported $0.52 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.50 by $0.02. The business had revenue of $71.40 million for the quarter, compared to the consensus estimate of $71.93 million. Petmed Express had a return on equity of 35.53% and a net margin of 14.88%. The firm’s revenue was up 7.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.43 EPS.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 16th. Investors of record on Monday, November 5th will be paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 3.84%. The ex-dividend date of this dividend is Friday, November 2nd. Petmed Express’s payout ratio is presently 59.34%.

In related news, Director Robert C. Schweitzer sold 7,500 shares of the firm’s stock in a transaction on Thursday, September 13th. The stock was sold at an average price of $37.00, for a total transaction of $277,500.00. Following the sale, the director now owns 88,334 shares of the company’s stock, valued at approximately $3,268,358. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 3.70% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Alps Advisors Inc. Has $436,000 Stake in Petmed Express Inc (PETS)” was posted by WKRB News and is the property of of WKRB News. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be read at https://www.wkrb13.com/2018/11/11/alps-advisors-inc-has-436000-stake-in-petmed-express-inc-pets.html.

Petmed Express Company Profile

PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Read More: How can you know how many shares are floating?

Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Petmed Express Inc (NASDAQ:PETS).

Institutional Ownership by Quarter for Petmed Express (NASDAQ:PETS)

Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply